Special Drug Use Investigation in patients with critical lower limb ischemia under conservative treatment - Special Drug Use Investigation in patients with critical lower limb ischemia under conservative treatment

AnGes, Inc.0 个研究点目标入组 82 人开始时间: 2021年7月31日最近更新: 2024年4月1日

试验速览

暂无简介。

•1) Patients with ulcers that expose bone or tendon, or gangrene, in the target or contralateral limb 2) Patients with extensive necrotic tissue or a life-threatening infection uncontrolled by antibiotics in the lower limb 3) Patients with current evidence or a history of malignant neoplasm in the target limb 4) Patients who underwent revascularization of the target limb within 4 weeks prior to registration However, this shall not apply if ischemia persists or is confirmed by an objective measure. 5) Patients with ischemic symptoms due to acute arterial occlusion in the target limb within 4 weeks prior to registration 6) Patients who are scheduled to undergo revascularization of the target limb within 12 weeks after registration 7) Patients who received Collategene 8) Patients who received angiogenic therapy other than Collategene or vascular regeneration therapy within 6 months prior to registration 9) Patients who previously participated in the investigation as a control patient 10) Other patients who, in the opinion of the investigator, are ineligible for the investigation

发起方